Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Neuromyelitis optica with very late onset.
Time to see the light.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Distraction adds to the cognitive burden in multiple sclerosis.
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS.
Towards establishing MS prevalence in Latin America and the Caribbean.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Variables associated with patient activation in persons with multiple sclerosis.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
Contribution of imaging to the diagnosis of optic neuropathies.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »